Is Arrowhead Pharmaceuticals, Inc. (ARWR) a Buy, Sell, or Hold?
NASDAQ : ARWR
Arrowhead Pharmaceuticals, Inc.
$74.3 USD
$2.92 (4.1%)
- Volume
- 3.78M
- Average Volume
- 2.1M
- Market Capitalization
- $10.47B
- P/E Ratio
- -34.72
- Dividend Yield
- 0.00%
- Price Target
- $94.00
- Year High
- $87.83
- Year Low
- $14.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.23
Institutional Ownership Summary
Institutional Ownership %
0.34%
Investors Holding
38
change: -421 | last: 459
Increased Positions
25
change: -251 | last: 276
Reduced Positions
6
change: -111 | last: 117
New Positions
11
change: -95 | last: 106
Sold Positions
415
change: 344 | last: 71
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -53.2988 | last: 0.533
Total Invested
38.91M
ARWR Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-09-30 | $34.49 | 133.76M | $4.61B | $226.55M | $366.28M | $4.75B |
| 2024-09-30 | $19.37 | 119.78M | $2.32B | $102.68M | $851.91M | $3.07B |
| 2023-09-30 | $26.87 | 107.31M | $2.88B | $110.89M | $383.5M | $3.16B |
| 2022-09-30 | $33.05 | 105.43M | $3.48B | $108M | $81.58M | $3.46B |
| 2021-09-30 | $62.43 | 103.74M | $6.48B | $184.43M | $25.54M | $6.32B |
| 2020-09-30 | $43.06 | 100.72M | $4.34B | $143.58M | $21.14M | $4.21B |
| 2019-09-30 | $28.18 | 93.86M | $2.64B | $221.8M | -$ | $2.42B |
| 2018-09-30 | $19.21 | 83.64M | $1.61B | $30.13M | $2.33M | $1.58B |
| 2017-09-30 | $4.33 | 73.15M | $316.74M | $24.84M | $2.53M | $294.43M |
| 2016-09-30 | $7.35 | 60.99M | $448.26M | $85.37M | $2.73M | $365.62M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62.70 | 142.42M | $8.93B | $188.52M | $1.37B | $10.11B |
| 2025-12-31 | $66.39 | 140.05M | $9.3B | $201.64M | $312.77M | $9.41B |
| 2025-09-30 | $34.49 | 135.7M | $4.68B | $226.55M | $366.28M | $4.82B |
| 2025-06-30 | $15.80 | 139.04M | $2.2B | $129.79M | $713.29M | $2.78B |
| 2025-03-31 | $12.74 | 133.36M | $1.7B | $185.71M | $740.51M | $2.25B |
| 2024-12-31 | $18.80 | 124.85M | $2.35B | $53.89M | $872.05M | $3.17B |
| 2024-09-30 | $19.37 | 121.99M | $2.36B | $102.68M | $851.91M | $3.11B |
| 2024-06-30 | $26.05 | 124.2M | $3.24B | $69.4M | $454.12M | $3.62B |
| 2024-03-31 | $28.24 | 123.28M | $3.48B | $127.7M | $399.86M | $3.75B |
| 2023-12-31 | $30.60 | 107.42M | $3.29B | $58.22M | $392.27M | $3.62B |
| 2023-09-30 | $26.87 | 107.31M | $2.88B | $110.89M | $383.5M | $3.16B |
| 2023-06-30 | $35.66 | 107M | $3.82B | $105.33M | $82.73M | $3.79B |